U.S. Stem Cell, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 3/20/2017
Contact Info
  • 13794 NW 4th Street
  • Suite 212
  • Sunrise, FL 33325

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001388319
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Incorporated In: FL, USA
Year of Inc. 1999
Employees Not Available
Company Officers/Contacts
Miguel Tomas President, CEO
Kristin Comella CSO
Jill Arlene Robbins Counsel
Company Directors
William P. Murphy Jr., M.D. Chairman
Sheldon Anderson
Mark P. Borman
Service Providers
Accounting/Auditing Firm
Fiondella, Milone & LaSaracina LLP
300 Winding Brook Dr
Glastonbury, CT, 06033
United States
Securities Counsel
Jill Arlene Robbins, P.A.
525 93 Street
Surfside, FL, 33154
United States
Investor Relations Firm

Not Available
Company History
  • Formerly=Bioheart, Inc. until 11-2015
USRM Security Details
Share Structure
Market Value1 $19,055,759 a/o Jun 26, 2017
Authorized Shares 2,000,000,000 a/o Aug 02, 2016
Outstanding Shares 335,429,659 a/o May 02, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Shareholders of Record 513 a/o Mar 15, 2017
Short Selling Data
Short Interest 1,000 (-98.4%)
Jun 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security